Types II and III congenital pulmonary airway malformation with hydrops treated in utero with percutaneous sclerotherapy

Abstract

The efficacy of percutaneous sclerotherapy for CPAM types II and III remains in question. Further studies are needed to determine the optimal dose of sclerotherapy agent and the safety and efficacy of this procedure.